These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical Significance of Epstein-Barr Virus and Noh JH; Shin JY; Lee JH; Park YS; Lee IS; Kim GH; Na HK; Ahn JY; Jung KW; Kim DH; Choi KD; Song HJ; Lee GH; Jung HY Gut Liver; 2023 Jan; 17(1):69-77. PubMed ID: 35611669 [TBL] [Abstract][Full Text] [Related]
5. Co-infection relationship with Epstein-Barr virus in gastroduodenal diseases with Helicobacter Pylori. Quantitative PCR and EBNA-1 gene-based approach. Akkus S; Gareayaghi N; Saribas S; Demiryas S; Ozbey D; Kepil N; Demirci M; Ziver Snap T; Oyku Dinc H; Akcin R; Uysal O; Tugberk Bakar M; Talha Aygun M; Bahar Tokman H; Kocazeybek B Acta Gastroenterol Belg; 2022; 85(2):301-308. PubMed ID: 35709774 [TBL] [Abstract][Full Text] [Related]
6. H pylori (CagA) and Epstein-Barr virus infection in gastric carcinomas: correlation with p53 mutation and c-Myc, Bcl-2 and Bax expression. Lima VP; de Lima MA; André AR; Ferreira MV; Barros MA; Rabenhorst SH World J Gastroenterol; 2008 Feb; 14(6):884-91. PubMed ID: 18240345 [TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus-associated gastric carcinomas: relation to H. pylori infection and genetic alterations. Wu MS; Shun CT; Wu CC; Hsu TY; Lin MT; Chang MC; Wang HP; Lin JT Gastroenterology; 2000 Jun; 118(6):1031-8. PubMed ID: 10833477 [TBL] [Abstract][Full Text] [Related]
8. Helicobacter pylori and Epstein-Barr Virus Coinfection Stimulates Aggressiveness in Gastric Cancer through the Regulation of Gankyrin. Kashyap D; Baral B; Jakhmola S; Singh AK; Jha HC mSphere; 2021 Oct; 6(5):e0075121. PubMed ID: 34585958 [TBL] [Abstract][Full Text] [Related]
9. CpG island methylator phenotype, Helicobacter pylori, Epstein-Barr virus, and microsatellite instability and prognosis in gastric cancer: a systematic review and meta-analysis. Zong L; Seto Y PLoS One; 2014; 9(1):e86097. PubMed ID: 24475075 [TBL] [Abstract][Full Text] [Related]
10. Case–control study of Epstein–Barr virus and Helicobacter pylori serology in Latin American patients with gastric disease. Cárdenas-Mondragón MG; Torres J; Flores-Luna L; Camorlinga-Ponce M; Carreón-Talavera R; Gomez-Delgado A; Kasamatsu E; Fuentes-Pananá EM Br J Cancer; 2015 Jun; 112(12):1866-73. PubMed ID: 25996206 [TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus infection associated with pepsinogens and Helicobacter pylori infection in patients with gastric cancer. Su X; Ye Z; Wang Z; Long Y; Qiu M; He C Virus Res; 2018 Sep; 256():1-5. PubMed ID: 30053417 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the Clinicopathological Characteristics and Genetic Alterations Between Patients with Gastric Cancer with or Without Fang WL; Huang KH; Chang SC; Lin CH; Chen MH; Chao Y; Lo SS; Li AF; Wu CW; Shyr YM Oncologist; 2019 Sep; 24(9):e845-e853. PubMed ID: 30796154 [TBL] [Abstract][Full Text] [Related]
13. Association between de Souza CRT; Almeida MCA; Khayat AS; da Silva EL; Soares PC; Chaves LC; Burbano RMR World J Gastroenterol; 2018 Nov; 24(43):4928-4938. PubMed ID: 30487702 [TBL] [Abstract][Full Text] [Related]
14. Status of kinases in Epstein-Barr virus and Helicobacter pylori Coinfection in gastric Cancer cells. Sonkar C; Verma T; Chatterji D; Jain AK; Jha HC BMC Cancer; 2020 Sep; 20(1):925. PubMed ID: 32993565 [TBL] [Abstract][Full Text] [Related]
15. Multiple infections by EBV, HCMV and Helicobacter pylori are highly frequent in patients with chronic gastritis and gastric cancer from Southwest Mexico: An observational study. Del Moral-Hernández O; Castañón-Sánchez CA; Reyes-Navarrete S; Martínez-Carrillo DN; Betancourt-Linares R; Jiménez-Wences H; de la Peña S; Román-Román A; Hernández-Sotelo D; Fernández-Tilapa G Medicine (Baltimore); 2019 Jan; 98(3):e14124. PubMed ID: 30653141 [TBL] [Abstract][Full Text] [Related]
16. Different pattern of allelic loss in Epstein-Barr virus-positive gastric cancer with emphasis on the p53 tumor suppressor pathway. van Rees BP; Caspers E; zur Hausen A; van den Brule A; Drillenburg P; Weterman MA; Offerhaus GJ Am J Pathol; 2002 Oct; 161(4):1207-13. PubMed ID: 12368194 [TBL] [Abstract][Full Text] [Related]
17. Dzikowiec M; Lik P; Kiszałkiewicz J; Kuczyńska A; Mordalski M; Nejc D; Piekarski J; Brzeziańska-Lasota E; Pastuszak-Lewandoska D Pol J Microbiol; 2022 Feb; 71(1):123-129. PubMed ID: 35635161 [TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus DNA load and its association with Helicobacter pylori infection in gastroduodenal diseases. Shukla SK; Prasad KN; Tripathi A; Singh A; Saxena A; Ghoshal UC; Krishnani N; Husain N Braz J Infect Dis; 2011; 15(6):583-90. PubMed ID: 22218519 [TBL] [Abstract][Full Text] [Related]
19. Correlation of Epstein-Barr virus and its encoded proteins with Helicobacter pylori and expression of c-met and c-myc in gastric carcinoma. Luo B; Wang Y; Wang XF; Gao Y; Huang BH; Zhao P World J Gastroenterol; 2006 Mar; 12(12):1842-8. PubMed ID: 16609989 [TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr Virus and Helicobacter pylori co-infection in patients with gastric cancer and duodenale ulcer. Gareayaghi N; Akkus S; Saribas S; Demiryas S; Ozbey D; Kepil N; Demirci M; Dinc HO; Akcin R; Uysal O; Tokman HB; Kocazeybek B New Microbiol; 2021 Oct; 44(4):217-226. PubMed ID: 34942011 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]